A Special Report on the Chitosan-Based Hemostatic Dressing: Experience in Current Combat Operations
Abstract
Hemorrhage remains a leading cause of death in both civilian and military trauma patients. The Hem-Con chitosan-based hemostatic dressing is approved by the US Food and Drug Administration (FDA) for hemorrhage control. Animal data have shown the HemCon dressing to reduce hemorrhage and improve survival. The purpose of this article is to report preliminary results of the hemostatic efficacy of the HemCon dressing used in the prehospital setting on combat casualties.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2006
- Accession Number
- ADA480357
Entities
People
- Anthony E. Pusateri
- Ian Wedmore
- John B Holcomb
- John G. McManus
Organizations
- United States Army Institute of Surgical Research